Genomics England have announced that they, in partnership with the GenOMICC consortium, are working with the NHS to deliver whole-genome […]
We’re now deep into lockdown, with perhaps some light at the end of the tunnel regarding some sort of return […]
The business impact of COVID-19 is proving to be significant. The post-COVID-19 world is going to look very different to […]
A study conducted by a team at UCL identified potential drug and vaccine targets for SARS-CoV-2. The results of the […]
I’m Luigi Grassi and I’m an Informatics Scientist at AstraZeneca. I’m responsible for designing and performing bioinformatical analyses of the […]
As headlines trumpet the continued spread of COVID-19, the wall-to-wall coverage has generated a secondary outbreak of breathless hype, misinformation and anxiety.
Arti Patel is an Information Officer at Unique, where she acts as the first point of contact on the helpline […]
Around 25% of the world is affected by a psychiatric disorder that can alter their behaviour, social relations and intellectual ability.
Shelley Simmonds is a patient advocate whose son has Duchenne muscular dystrophy. Duchenne causes muscle weakening and wasting and is […]
FLG: Can you introduce yourself and your work? I’m Sandra Smieszek and I’m the Head of Genetics at Vanda Pharmaceuticals […]
